Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

111 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Not yet recruiting

Interest of Magnetic Resonance Imaging in the Diagnosis of Upper Urinary Tract Invasive Tumours

NCT07252882

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Magnetic Resonance Imaging (MRI), +8 more
Locations
  • Hôpital Pellegrin Bordeaux, France
  • Hôpital Claude Huriez Lille, France
  • Institut Paoli Calmettes Marseille, France
  • Clinique Beau Soleil Montpellier, France
View Trial Details
Active, not recruiting

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

NCT04579380

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Breast Diseases, +37 more
Locations
  • HonorHealth Phoenix, Arizona, United States
  • HonorHealth Tempe, Arizona, United States
  • The University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • City of Hope at Huntington Beach Huntington Beach, California, United States
View all 108 locations
View Trial Details
Active, not recruiting

Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab

NCT06237920

Conditions
Antineoplastics Toxicity, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • Rijnstate Arnhem, Gelderland, Netherlands
  • Radboud University Medical Center Nijmegen, Gelderland, Netherlands
  • NKI-AVL Amsterdam, North Holland, Netherlands
  • Amsterdam UMC (AUMC) Amsterdam, North Holland, Netherlands
View Trial Details
Active, not recruiting

Savolitinib vs. Sunitinib in MET-driven PRCC.

NCT03091192

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Iowa City, Iowa, United States
View all 59 locations
View Trial Details
Active, not recruiting

A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT

NCT06111235

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +17 more
Locations
  • Urology Centers of Alabama PC Homewood, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Arizona Institute of Urology PLLC Tucson, Arizona, United States
View all 95 locations
View Trial Details

Related conditions